VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Celsius Therapeutics

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 75 out of 100

  • Other
Open relationship map
Claim, correct or request removal

Record updated 17 September 2026

About

Celsius Therapeutics is a clinical-stage biotechnology company developing novel medicines in inflammatory disease. The company's lead therapeutic candidate is an anti-TREM1 antibody for the treatment of IBD. Celsius was acquired by AbbVie in June 2024.

About the company

Status notes
Celsius was acquired by AbbVie in June 2024.

Exit

Acquisition
2024-06
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy